Skip to main content
Top
Published in: Diabetologia 10/2008

Open Access 01-10-2008 | Review

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause

Author: R. Taylor

Published in: Diabetologia | Issue 10/2008

Login to get access

Abstract

The metabolic abnormalities of type 2 diabetes can be reversed reproducibly by bariatric surgery. By quantifying the major pathophysiological abnormalities in insulin secretion and insulin action after surgery, the sequence of events leading to restoration of normal metabolism can be defined. Liver fat levels fall within days and normal hepatic insulin sensitivity is restored. Simultaneously, plasma glucose levels return towards normal. Insulin sensitivity of muscle remains abnormal, at least over the weeks and months after bariatric surgery. The effect of the surgery is explicable solely in terms of energy restriction. By combining this information with prospective observation of the changes immediately preceding the onset of type 2 diabetes, a clear picture emerges. Insulin resistance in muscle, caused by inherited and environmental factors, facilitates the development of fatty liver during positive energy balance. Once established, the increased insulin secretion required to maintain plasma glucose levels will further increase liver fat deposition. Fatty liver causes resistance to insulin suppression of hepatic glucose output as well as raised plasma triacylglycerol. Exposure of beta cells to increased levels of fatty acids, derived from circulating and locally deposited triacylglycerol, suppresses glucose-mediated insulin secretion. This is reversible initially, but eventually becomes permanent. The essential time sequence of the pathogenesis of type 2 diabetes is now evident. Muscle insulin resistance determines the rate at which fatty liver progresses, and ectopic fat deposition in liver and islet underlies the related dynamic defects of hepatic insulin resistance and beta cell dysfunction. These defects are capable of dramatic reversal under hypoenergetic feeding conditions, completely in early diabetes and to a worthwhile extent in more established disease.
Literature
1.
go back to reference Hall RA, Hall MR (eds) (1962) Unpublished scientific papers of Isaac Newton. Cambridge University Press, Cambridge, pp 11–14 Hall RA, Hall MR (eds) (1962) Unpublished scientific papers of Isaac Newton. Cambridge University Press, Cambridge, pp 11–14
2.
go back to reference Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323PubMedCrossRef Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:316–323PubMedCrossRef
3.
go back to reference Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737PubMedCrossRef Buchwald H, Avidor Y, Braunwald E et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292:1724–1737PubMedCrossRef
4.
go back to reference Pories WJ, Caro JF, Flickinger EG, Meelheim HD, Swanson MS (1987) The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann Surg 206:316–323PubMedCrossRef Pories WJ, Caro JF, Flickinger EG, Meelheim HD, Swanson MS (1987) The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann Surg 206:316–323PubMedCrossRef
5.
go back to reference Camastra S, Manco M, Mari A et al (2007) Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care 30:1002–1004PubMedCrossRef Camastra S, Manco M, Mari A et al (2007) Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care 30:1002–1004PubMedCrossRef
6.
go back to reference Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025–2031PubMedCrossRef Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025–2031PubMedCrossRef
7.
go back to reference Gibney ER, Murgatroyd P, Wright A, Jebb S, Elia M (2003) Measurement of total energy expenditure in grossly obese women: comparison of the bicarbonate–urea method with whole-body calorimetry and free-living doubly labelled water. Int J Obes Relat Metab Disord 27:641–647PubMedCrossRef Gibney ER, Murgatroyd P, Wright A, Jebb S, Elia M (2003) Measurement of total energy expenditure in grossly obese women: comparison of the bicarbonate–urea method with whole-body calorimetry and free-living doubly labelled water. Int J Obes Relat Metab Disord 27:641–647PubMedCrossRef
8.
go back to reference DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterisation. Diabetes 30:1001–1007 DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterisation. Diabetes 30:1001–1007
9.
go back to reference Firth R, Bell P, Rizza R (1987) Insulin action in non-insulin dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism 36:1091–1095PubMedCrossRef Firth R, Bell P, Rizza R (1987) Insulin action in non-insulin dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism 36:1091–1095PubMedCrossRef
10.
go back to reference Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608PubMedCrossRef Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54:603–608PubMedCrossRef
11.
go back to reference Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE (2006) Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr 84:304–311PubMed Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE (2006) Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr 84:304–311PubMed
12.
go back to reference Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100PubMedCrossRef Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91–100PubMedCrossRef
13.
go back to reference Hollingsworth KG, Abubacker MZ, Joubert I, Allison ME, Lomas DJ (2006) Low-carbohydrate diet induced reduction of hepatic lipid content observed with a rapid non-invasive MRI technique. Br J Radiol 79:712–715PubMedCrossRef Hollingsworth KG, Abubacker MZ, Joubert I, Allison ME, Lomas DJ (2006) Low-carbohydrate diet induced reduction of hepatic lipid content observed with a rapid non-invasive MRI technique. Br J Radiol 79:712–715PubMedCrossRef
14.
go back to reference Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023–3028PubMedCrossRef Seppala-Lindroos A, Vehkavaara S, Hakkinen AM et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023–3028PubMedCrossRef
15.
go back to reference Ryysy L, Hakkinen A-M, Goto T et al (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749–758PubMedCrossRef Ryysy L, Hakkinen A-M, Goto T et al (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749–758PubMedCrossRef
16.
go back to reference Ferner RE, Ashworth L, Tronier B, Alberti KGMM (1986) Effects of short-term hyperglycaemia on insulin secretion in normal humans. Am J Physiol 250:E655–E661PubMed Ferner RE, Ashworth L, Tronier B, Alberti KGMM (1986) Effects of short-term hyperglycaemia on insulin secretion in normal humans. Am J Physiol 250:E655–E661PubMed
17.
go back to reference Tushuizen ME, Bunck MC, Pouwels PJ et al (2007) Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916–2921PubMedCrossRef Tushuizen ME, Bunck MC, Pouwels PJ et al (2007) Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916–2921PubMedCrossRef
18.
go back to reference Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH (1994) β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte–β-cell relationships. Proc Natl Acad Sci USA 91:10878–10882PubMedCrossRef Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH (1994) β-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte–β-cell relationships. Proc Natl Acad Sci USA 91:10878–10882PubMedCrossRef
19.
go back to reference Boucher A, Lu D, Burgess SC et al (2004) Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J Biol Chem 279:27263–27271PubMedCrossRef Boucher A, Lu D, Burgess SC et al (2004) Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J Biol Chem 279:27263–27271PubMedCrossRef
20.
go back to reference Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44–52PubMedCrossRef Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44–52PubMedCrossRef
21.
go back to reference Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388–1393PubMedCrossRef Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388–1393PubMedCrossRef
22.
go back to reference Perseghin G, Bonfanti R, Magni S et al (2006) Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 291:E697–E703PubMedCrossRef Perseghin G, Bonfanti R, Magni S et al (2006) Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 291:E697–E703PubMedCrossRef
23.
go back to reference Perseghin G, Lattuada G, De Cobelli F et al (2007) Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 30:683–688PubMedCrossRef Perseghin G, Lattuada G, De Cobelli F et al (2007) Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 30:683–688PubMedCrossRef
24.
go back to reference Toussaint-Samat M (1994) History of food. Blackwell, Oxford, pp 424–433 Toussaint-Samat M (1994) History of food. Blackwell, Oxford, pp 424–433
25.
go back to reference Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR (1996) Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 98:2244–2250PubMedCrossRef Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR (1996) Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. J Clin Invest 98:2244–2250PubMedCrossRef
26.
go back to reference Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43–50PubMed Schwarz JM, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43–50PubMed
27.
go back to reference Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK (1995) Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest 96:2735–2743PubMedCrossRef Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK (1995) Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest 96:2735–2743PubMedCrossRef
28.
go back to reference McGarry JD, Mannaerts GP, Foster DW (1977) A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 60:265–270PubMedCrossRef McGarry JD, Mannaerts GP, Foster DW (1977) A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 60:265–270PubMedCrossRef
29.
go back to reference Perseghin G, Lattuada G, De Cobelli F et al (2005) Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 48:2615–2621PubMedCrossRef Perseghin G, Lattuada G, De Cobelli F et al (2005) Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes. Diabetologia 48:2615–2621PubMedCrossRef
30.
go back to reference Nobili V, Marcellini M, Marchesini G et al (2007) Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care 30:2638–2640PubMedCrossRef Nobili V, Marcellini M, Marchesini G et al (2007) Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children. Diabetes Care 30:2638–2640PubMedCrossRef
31.
go back to reference Sreenivasa Baba C, Alexander G, Kalyani B et al (2006) Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 21:191–198PubMedCrossRef Sreenivasa Baba C, Alexander G, Kalyani B et al (2006) Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 21:191–198PubMedCrossRef
32.
go back to reference Belfort R, Harrison SA, Brown K et al (2006) A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355:2297–2307PubMedCrossRef Belfort R, Harrison SA, Brown K et al (2006) A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 355:2297–2307PubMedCrossRef
33.
go back to reference Ravikumar B, Gerrard J, Dalla Man C et al (2008) Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content. Diabetes doi:10.2337/db07-1828 Ravikumar B, Gerrard J, Dalla Man C et al (2008) Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content. Diabetes doi:10.​2337/​db07-1828
34.
go back to reference Juurinen L, Tiikkainen M, Hakkinen AM, Hakkarainen A, Yki-Jarvinen H (2007) Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 292:E829–E835PubMedCrossRef Juurinen L, Tiikkainen M, Hakkinen AM, Hakkarainen A, Yki-Jarvinen H (2007) Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab 292:E829–E835PubMedCrossRef
35.
go back to reference Bock G, Chittilapilly EG, Basu R et al (2007) Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose. Role of increased rates of gluconeogenesis. Diabetes 56:1703–1711PubMedCrossRef Bock G, Chittilapilly EG, Basu R et al (2007) Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose. Role of increased rates of gluconeogenesis. Diabetes 56:1703–1711PubMedCrossRef
36.
go back to reference Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M (2007) Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30:2940–2944PubMedCrossRef Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M (2007) Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 30:2940–2944PubMedCrossRef
37.
go back to reference Cali AM, Zern TL, Taksali SE et al (2007) Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care 30:3093–3098PubMedCrossRef Cali AM, Zern TL, Taksali SE et al (2007) Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care 30:3093–3098PubMedCrossRef
38.
go back to reference Sattar N, McConnachie A, Ford I et al (2007) Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 56:984–991PubMedCrossRef Sattar N, McConnachie A, Ford I et al (2007) Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 56:984–991PubMedCrossRef
39.
go back to reference Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212–1218PubMedCrossRef Targher G, Bertolini L, Padovani R et al (2007) Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 30:1212–1218PubMedCrossRef
40.
go back to reference Turnbull AJ, Mitchison HC, Peaston RTP et al (1997) The prevalence of hereditary haemochromatosis in a diabetic population in north-east England. Quart J Med 90:271–275 Turnbull AJ, Mitchison HC, Peaston RTP et al (1997) The prevalence of hereditary haemochromatosis in a diabetic population in north-east England. Quart J Med 90:271–275
41.
go back to reference Suzuki A, Angulo P, Lymp J et al (2005) Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 41:64–71PubMedCrossRef Suzuki A, Angulo P, Lymp J et al (2005) Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 41:64–71PubMedCrossRef
42.
go back to reference Nobili V, Marcellini M, Devito R et al (2006) NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44:458–465PubMedCrossRef Nobili V, Marcellini M, Devito R et al (2006) NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44:458–465PubMedCrossRef
43.
go back to reference Rasmussen SS, Glumer C, Sandbaek A, Lauritzen T, Borch-Johnsen K (2008) Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia 51:249–257PubMedCrossRef Rasmussen SS, Glumer C, Sandbaek A, Lauritzen T, Borch-Johnsen K (2008) Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark. Diabetologia 51:249–257PubMedCrossRef
44.
go back to reference Singhal P, Caumo A, Carey PE, Cobelli C, Taylor R (2002) Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol Endocrinol Metab 283:E275–E283PubMed Singhal P, Caumo A, Carey PE, Cobelli C, Taylor R (2002) Regulation of endogenous glucose production after a mixed meal in type 2 diabetes. Am J Physiol Endocrinol Metab 283:E275–E283PubMed
45.
go back to reference Carey PE, Halliday J, Snaar JEM, Morris PG, Taylor R (2003) Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. Am J Physiol 284:E286–E294 Carey PE, Halliday J, Snaar JEM, Morris PG, Taylor R (2003) Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. Am J Physiol 284:E286–E294
46.
go back to reference Adiels M, Westerbacka J, Soro-Paavonen A et al (2007) Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50:2356–2365PubMedCrossRef Adiels M, Westerbacka J, Soro-Paavonen A et al (2007) Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50:2356–2365PubMedCrossRef
47.
go back to reference Bennett PH (1999) Type 2 diabetes among the Pima Indians of Arizona: an epidemic attributable to environmental change. Nutr Rev 57:S51–S54PubMed Bennett PH (1999) Type 2 diabetes among the Pima Indians of Arizona: an epidemic attributable to environmental change. Nutr Rev 57:S51–S54PubMed
Metadata
Title
Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause
Author
R. Taylor
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1116-7

Other articles of this Issue 10/2008

Diabetologia 10/2008 Go to the issue